Circulating levels of TNF-related apoptosis inducing-ligand are decreased in patients with large adult-type granulosa cell tumors-implications for therapeutic potential

Show full item record



Permalink

http://hdl.handle.net/10138/229286

Citation

Farkkila , A , Zauli , G , Haltia , U-M , Pihlajoki , M , Unkila-Kallio , L , Secchiero , P & Heikinheimo , M 2016 , ' Circulating levels of TNF-related apoptosis inducing-ligand are decreased in patients with large adult-type granulosa cell tumors-implications for therapeutic potential ' , Tumor Biology , vol. 37 , no. 9 , pp. 11909-11916 . https://doi.org/10.1007/s13277-016-5042-x

Title: Circulating levels of TNF-related apoptosis inducing-ligand are decreased in patients with large adult-type granulosa cell tumors-implications for therapeutic potential
Author: Farkkila, Anniina; Zauli, Giorgio; Haltia, Ulla-Maija; Pihlajoki, Marjut; Unkila-Kallio, Leila; Secchiero, Paola; Heikinheimo, Markku
Contributor: University of Helsinki, Clinicum
University of Helsinki, Department of Obstetrics and Gynecology
University of Helsinki, Clinicum
University of Helsinki, Clinicum
University of Helsinki, Clinicum
Date: 2016-09
Language: eng
Number of pages: 8
Belongs to series: Tumor Biology
ISSN: 1010-4283
URI: http://hdl.handle.net/10138/229286
Abstract: Targeted treatments are needed for advanced adult-type granulosa cell tumors (AGCTs). We set out to assess tumor tissue and circulating levels of TNF-related apoptosis-inducing ligand (TRAIL), a promising anti-cancer cytokine, in patients affected by AGCT. We analyzed tissue expression of TRAIL in 127 AGCTs using immunohistochemistry or RT-PCR. Soluble TRAIL was measured by means of ELISA from 141 AGCT patient serum samples, as well as the conditioned media of 15 AGCT patient-derived primary cell cultures, and the KGN cell line. Tissue and serum TRAIL levels were analyzed in relationship with clinical parameters, and serum estradiol, FSH, and LH levels. We found that AGCT samples expressed TRAIL mRNA and protein at levels comparable to normal granulosa cells. AGCT cells did not release soluble TRAIL. TRAIL protein levels were decreased in tumors over 10 cm in diameter (p = 0.04). Consistently, circulating TRAIL levels correlated negatively to tumor dimension (p = 0.01). Circulating TRAIL levels negatively associated with serum estradiol levels. In multiple regression analysis, tumor size was an independent factor contributing to the decreased levels of soluble TRAIL in AGCT patients. AGCTs associate with significantly decreased tumor tissue and serum TRAIL levels in patients with a large tumor mass. These findings encourage further study of agonistic TRAIL treatments in patients with advanced or recurrent AGCT.
Subject: Estradiol
FSH
GATA4
Granulosa cell tumor
LH
Ovarian cancer
Targeted treatment
TRAIL
ENDOTHELIAL GROWTH-FACTOR
DULANERMIN RHAPO2L/TRAIL
R DEFICIENCY
CANCER
OVARY
EXPRESSION
RECEPTOR
DEATH
BEVACIZUMAB
3122 Cancers
Rights:


Files in this item

Total number of downloads: Loading...

Files Size Format View
art_3A10.1007_2Fs13277_016_5042_x.pdf 959.4Kb PDF View/Open

This item appears in the following Collection(s)

Show full item record